Table 4. Multivariable models for Endline survey (2015)^.
| Unadjusted values | Adjusted values | ||||
|---|---|---|---|---|---|
| N | OR (95% CI) | P value | AOR (95% CI) | P value | |
| Ever received LF drugs during MDA (N = 811) | |||||
| Age | |||||
| 15–25 years | 99 | 1.00 | 1.00 | ||
| 26–35 | 208 | 1.96 (0.8–4.65) | 0.128 | 2.12 (0.8–5.3) | 0.107 |
| 36–45 | 195 | 3.21 (0.9–10.6) | 0.056 | 3.22 (1.1–9.1) | 0.028 |
| 46–55 | 155 | 4.09 (0.9–16.8) | 0.05 | 4.47 (1.2–16.2) | 0.023 |
| 56+ | 154 | 2.02 (0.6–6.5) | 0.237 | 1.68 (0.6–4.4) | 0.291 |
| Occupation | |||||
| Housewife | 304 | 1.00 | 1.00 | ||
| Private | 237 | 0.29 (0.1–0.6) | 0.002 | 0.28 (0.1–0.6) | 0.002 |
| Informal | 137 | 3.51 (0.6–20.9) | 0.166 | 3.74 (0.7–20.1) | 0.123 |
| Other | 133 | 0.35 (0.1–0.9) | 0.029 | 0.57 (0.2–1.3) | 0.196 |
| Ever taken LF drug (N = 717) | |||||
| Location | |||||
| Agam | 405 | 1.00 | 1.00 | ||
| Depok | 312 | 0.64 (0.3–1.2) | 0.148 | 0.44 (0.2–1.0) | 0.056 |
| Age | |||||
| 15–25 years | 77 | 1.00 | 1.00 | ||
| 26–35 | 181 | 0.30 (0.1–0.9) | 0.038 | 0.19 (0.0–1.2) | 0.082 |
| 36–45 | 179 | 0.37 (0.1–1.1) | 0.061 | 0.07 (0.0–0.4) | 0.006 |
| 46–55 | 145 | 0.77 (0.2–2.5) | 0.652 | 0.16 (0.0–1.2) | 0.078 |
| 56+ | 135 | 0.4 (0.1–1.4) | 0.157 | 0.15 (0.0–1.2) | 0.075 |
| Income** | |||||
| Less than minimum wage | 350 | 1.00 | 1.00 | ||
| Equal to or more than minimum wage | 338 | 0.68 (0.3–1.5) | 0.330 | 0.23 (0.1–0.7) | 0.007 |
| Perceived safety of drugs | |||||
| Dangerous | 45 | 1.00 | 1.00 | ||
| Neutral | 172 | 5.00 (1.8–13.9) | 0.002 | 3.66 (1.0–13.4) | 0.050 |
| Safe | 500 | 21.56 (8.3–56.4) | 0.000 | 6.33 (1.7–22.9) | 0.005 |
| Aware of MDA prior to drug distribution | |||||
| Yes | 614 | 1.00 | 1.00 | ||
| No | 103 | 0.29 (0.1–0.7) | 0.003 | 0.30 (0.1–0.8) | 0.020 |
| Perceived importance of LF drugs for health | |||||
| Unimportant for health | 21 | 1.00 | 1.00 | ||
| Neutral | 69 | 13.77 (3.1–60.8) | 0.001 | 23.04 (3.7–142.6) | 0.001 |
| Important for health | 627 | 67.01 (14.7–305.6) | 0.000 | 42.63 (7.2–252.6) | <0.001 |
| Influencing the decision to comply** | |||||
| Myself (no outside influence) | 423 | 1.00 | 1.00 | ||
| Others | 288 | 3.34 (1.6–7.2) | 0.002 | 2.65 (1.1–6.5) | 0.034 |
| Knows the deliverer | |||||
| Yes | 640 | 1.00 | 1.00 | ||
| No | 77 | 0.22 (0.1–0.5) | 0.001 | 0.18 (0.1–0.5) | 0.001 |
| Knows another household member who took LF drugs | |||||
| Yes | 598 | 1.00 | 1.00 | ||
| No / Don’t know | 119 | 0.07 (0.03–0.2) | <0.001 | 0.11 (0.0–0.3) | <0.001 |
| Possible negative or positive effects of MDA on health** | |||||
| Less important | 219 | 1.00 | 1.00 | ||
| Important | 265 | 1.70 (0.5–5.4) | 0.362 | 1.37 (0.3–5.5) | 0.656 |
| Very important | 214 | 0.21 (0.1–0.5) | 0.001 | 0.27 (0.1–0.8) | 0.019 |
| Compliance in the last MDA (N = 665) | |||||
| Location | |||||
| Agam | 365 | 1.00 | 1.00 | ||
| Depok | 300 | 0.39 (0.2–0.7) | 0.001 | 0.26 (0.1–0.5) | <0.001 |
| Age | |||||
| 15–25 years | 70 | 1.00 | 1.00 | ||
| 26–35 | 166 | 0.51 (0.3–1.0) | 0.060 | 0.60 (0.2–2.0) | 0.401 |
| 36–45 | 174 | 1.05 (0.5–2.1) | 0.885 | 1.26 (0.4–4.2) | 0.711 |
| 46–55 | 134 | 1.93 (0.9–4.2) | 0.096 | 3.76 (1.0–13.6) | 0.044 |
| 56+ | 121 | 1.42 (0.6–3.5) | 0.440 | 3.06 (0.7–13.4) | 0.135 |
| Perceived importance of LF drugs for health | |||||
| Unimportant for health | 21 | 1.00 | 1.00 | ||
| Neutral | 57 | 11.03 (1.2–98.6) | 0.032 | 30.83 (3.6–263.9) | 0.002 |
| Important for health | 587 | 34.01 (3.9–296.8) | 0.002 | 42.76 (4.8–380.4) | 0.001 |
| Perceived safety of drugs** | |||||
| Dangerous | 42 | 1.00 | 1.00 | ||
| Neutral | 156 | 2.59 (1.0–6.6) | 0.045 | 1.74 (0.5–5.9) | 0.370 |
| Safe | 466 | 8.07 (3.1–20.8) | <0.001 | 3.73 (1.2–11.9) | 0.027 |
| Cause of LF** | |||||
| Worms | 126 | 1.00 | 1.00 | ||
| Mosquitoes | 230 | 0.81 (0.4–1.5) | 0.494 | 0.56 (0.2–1.3) | 0.187 |
| Don’t know | 257 | 0.37 (0.2–0.8) | 0.016 | 0.25 (0.1–0.6) | 0.005 |
| Other | 29 | 0.75 (0.3–2.3) | 0.615 | 0.42 (0.1–1.6) | 0.204 |
| Possible negative or positive effects of MDA on health** | |||||
| Less important | 199 | 1.00 | 1.00 | ||
| Important | 251 | 1.31 (0.6–3.1) | 0.529 | 1.02 (0.5–2.2) | 0.960 |
| Very important | 200 | 0.29 (0.1–0.6) | 0.001 | 0.42 (0.2–0.9) | 0.016 |
| Length of stay in the survey district | |||||
| <2 years | 30 | 1.00 | 1.00 | ||
| 2+ years | 635 | 0.66 (0.2–2.2) | 0.499 | 0.06 (0.01–0.3) | 0.001 |
| Knows another household member who took LF drugs | |||||
| Yes | 565 | 1.00 | 1.00 | ||
| No | 100 | 0.10 (0.1–0.2) | <0.001 | 0.16 (0.1–0.3) | <0.001 |
^Variables with p<0.05 were included in the final models.
**Missing values.